|
Volumn 33, Issue 5, 2002, Pages 195-204
|
Pharmacokinetic profile of BAY a 1040 GITS, a nifedipine once-a-day dosage form based on osmotic pump configuration
|
Author keywords
GITS (gastrointestinal therapeutic system); Nifedipine; Pharmacokinetics; Slow release formulation
|
Indexed keywords
ADALAT CR;
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
NIFEDIPINE;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
AREA UNDER THE CURVE;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
BLOOD PRESSURE MEASUREMENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED DRUG RELEASE;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DIET RESTRICTION;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DOSE REGIMEN;
DRUG HALF LIFE;
DRUG SAFETY;
ENTERIC COATED TABLET;
HEADACHE;
HUMAN;
HUMAN EXPERIMENT;
JAPAN;
LIPID DIET;
LIVER TOXICITY;
MULTIPLE DRUG DOSE;
NORMAL HUMAN;
OPEN STUDY;
OSMOTIC PUMP;
PHARMACOKINETICS;
PULSE RATE;
RANDOMIZED CONTROLLED TRIAL;
SINGLE DRUG DOSE;
SLOW RELEASE FORMULATION;
TABLET;
TACHYCARDIA;
VERTIGO;
|
EID: 0041319076
PISSN: 03881601
EISSN: None
Source Type: Journal
DOI: 10.3999/jscpt.33.5_195 Document Type: Article |
Times cited : (1)
|
References (10)
|